Kyntra Bio Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.81 -0.33 (-3.61%) USD | NASDAQ | Jan 20, 16:00

8.59 -0.22 (-2.50%) After-Hours: 19:28

View Preferred Securities out of Shareholders Equity (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	--
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	--
Myomo, Inc.	--